Moderna Spikevax COVID-19 Vaccine
Spikevax is an mRNA-based COVID-19 vaccine encoding the SARS-CoV-2 spike protein to elicit immune response. As a biotechnologically produced immunological product in pre-filled syringes for retail sale, it fits HTS 3002.15.00.
Import Duty Rates by Country of Origin
More Specific Codes
This product may fall under a more specific subheading:
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Maintain -70°C ultra-cold chain with validated shipping containers and temperature logs
• Submit IND or BLA documentation; declare as finished dosage form
• Beware expiry date issues leading to waste pharma classification under 3006.92
Related Products under HTS 3002.15.00
Pfizer Prevnar 13 Pneumococcal Vaccine
Prevnar 13 is a 13-valent pneumococcal conjugate vaccine used to prevent invasive disease caused by Streptococcus pneumoniae in infants and adults. It contains purified capsular polysaccharides conjugated to a carrier protein, qualifying as an immunological product under HTS 3002.15.00 due to its measured doses packaged for retail sale in pre-filled syringes.
Merck Gardasil 9 HPV Vaccine
Gardasil 9 vaccine targets nine HPV types with virus-like particles (VLPs) for cervical cancer prevention. As a measured-dose retail product, it falls under immunological products of HTS 3002.15.00.
Bavarian Nordic Imvamune Smallpox Vaccine
Imvamune is a non-replicating modified vaccinia Ankara vaccine for smallpox/mpox protection. Its immunological nature and retail dosing qualify for HTS 3002.15.00.
Seqirus Flucelvax Influenza Vaccine
Flucelvax is cell culture-derived inactivated influenza vaccine with four strains. Packaged in measured doses for retail sale, it's an immunological product under HTS 3002.15.00.
Regeneron Casimvy Gene Therapy
Casimvy uses CRISPR/Cas9 ex vivo to edit CD34+ cells for sickle cell disease, administered as immunological cell therapy. As a measured-dose biotech product for retail, it fits HTS 3002.15.00.
BioNTech Comirnaty COVID-19 Vaccine
Comirnaty is Pfizer's mRNA COVID-19 vaccine in multi-dose vials for retail sale. Its spike protein induction classifies it as an immunological product under HTS 3002.15.00.